Search

Your search keyword '"Stock options"' showing total 43,340 results

Search Constraints

Start Over You searched for: Descriptor "Stock options" Remove constraint Descriptor: "Stock options"
43,340 results on '"Stock options"'

Search Results

1. Overcoming Arbitrage Limits: Option Trading and Momentum Returns.

2. THE $100 BILLION CLUB.

3. The Only Constant Is Change: Nonconstant Volatility and Implied Volatility Spreads.

4. Exploring the Role of Stock Liquidity in CEO Equity Compensation Design.

5. Option compensation, dynamic investment and capital structure.

6. Efficient pricing and calibration of high-dimensional basket options.

7. The nonlinear relationship between financial constraints and R&D investment: the mediating role of executive stock options.

8. The governing role of board gender diversity on conditional accounting conservatism and executive remuneration: performance-based versus equity-based remunerations.

9. A rational finance explanation of the stock predictability puzzle.

10. Efficient pricing of path‐dependent interest rate derivatives.

11. CEO stock option pay and risk‐taking investment in the hospitality industry: The moderating effects of situational factors.

12. When do stock options affect CEO risk‐taking? The moderating role of CEO regulatory focus.

13. Simulations of a dynamical portfolio consist of stocks and options for investment during the COVID-19 pandemic.

14. Illiquidity and Higher Cumulants.

15. The effect of optimal investment by stock options incentive under economic policy uncertainty.

16. Employee behavior in employee stock option plans: Why do some employees acquire company stock?

17. A Preconditioned Policy–Krylov Subspace Method for Fractional Partial Integro-Differential HJB Equations in Finance.

18. Linzagolix therapy versus a placebo in patients with endometriosis-associated pain: a prospective, randomized, double-blind, Phase 3 study (EDELWEISS 3).

19. Employee financial participation and corporate social and environmental performance: Evidence from European panel data.

20. Justifications for minority co-owned groups and their corporate law implications.

21. Excess cash and equity option liquidity.

22. Managerial ability and R&D investment: do CEOs' and firms' characteristics matter?

23. Quality issues of implied volatilities of index and stock options in the OptionMetrics IvyDB database.

24. Activity of informed traders and stock returns.

25. Brain activity of professional investors signals future stock performance.

26. Steuerrechtliche Einkünftekorrektur wegen Ausgestaltung von Darlehen zwischen konzernangehörigen Gesellschaften mit Sitz in unterschiedlichen EU-Mitgliedsstaaten – (konkludente) Annahme eines „acte clair" bzw. eines „acte éclairé" auf Grundlage der EuGH-Entscheidung „Hornbach-Baumarkt"

27. Zur Besteuerung von Stock Options im Fall des Ansässigkeitswechsels.

28. Knock-in options of mean-reverting stock model with floating interest rate in uncertain environment.

29. Martingale defects in the volatility surface and bubble conditions in the underlying.

30. Risky business: How standardization as coordination tool in ecosystems impacts firm‐level uncertainty.

31. Finite difference for stock option simulations based on Black Scholes models.

32. Relative Versus Absolute Performance Evaluation and CEO Decision-Making.

33. Determinants and Consequences of the Severity of Executive Compensation Clawbacks.

34. ReShape Lifesciences announces 1-for-58 reverse stock split

35. PowerBand Solutions announces results of Annual General, Special Meeting

36. Elicio Therapeutics reports inducement grants

37. EyePoint reports inducement grants under NASDAQ listing rule

38. Viridian Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

39. Aligos Therapeutics announces inducement grants under Nasdaq listing rule

42. Taysha Gene Therapies announces inducement grant under Nasdaq listing rule

43. Adverum Biotechnologies reports inducement grants under Nasdaq listing rule

44. Vaxart reports inducement grants under Nasdaq listing rule

45. Innocan Pharma completes private placement and awards stock options

49. 768 Entities Settled Stock Options Cases Under SEBIas 2024 Settlement Scheme

50. From the editor

Catalog

Books, media, physical & digital resources